Innovative Medicines Canada has an effective and engaged Board of Directors that enables member companies to achieve common objectives.
Ronnie W. Miller, Hoffmann-La Roche Limited
Cole Pinnow, Pfizer Canada ULC
Jorge Bartolome, Janssen Inc.
Jane Chung, AstraZeneca Canada Inc.
Ed Dybka, Ipsen Biopharmaceuticals Canada, Inc.
Rute Fernandes, Takeda Canada Inc.
Brian Heath, Amgen Canada Inc.
Alok Kanti, Bayer Inc.
Melissa Koomey, Gilead Sciences Canada, Inc.
Christian Macher, Novartis Pharmaceuticals Canada Inc.
Lisa Mullett, Sunovion Pharmaceuticals Canada Inc.
Marissa Poole, Sanofi Canada
Tracey Ramsay, AbbVie Corporation
Frank Stramaglia, Astellas Pharma Canada, Inc.